Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Cited by (1,054)

Items 701–800 of 1,054

1. Resistance training, visceral obesity and inflammatory response: a review of the evidence
   Barbara Strasser, Marjan Arvandi, Uwe Siebert · 2012 · Obesity Reviews
2. Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets
   Douglas B. DiRienzo · 2013 · Nutrition Reviews
3. Inflammation and thrombosis in cardiovascular disease
   Prabhakara R. Nagareddy, Susan S. Smyth · 2013 · Current Opinion in Hematology
4. Non‐surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial
   Syed Akhtar Hussain Bokhari, Ayyaz Ali Khan, Arshad Kamal Butt, Mohammad Azhar, Mohammad Hanif, Mateen Izhar, Dimitris N. Tatakis · 2012 · Journal Of Clinical Periodontology
5. Endothelial Function as a Functional Expression of Cardiovascular Risk Factors
   Martin Reriani, Lilach O. Lerman, Amir Lerman · 2010 · Biomarkers in Medicine
6. High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome
   Jiejie Li, Xingquan Zhao, Xia Meng, Jinxi Lin, Liping Liu, Chunxue Wang, Anxin Wang, Yilong Wang, Yongjun Wang, on behalf of the CHANCE Investigators · 2016 · Stroke
7. Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank
   Claire E. Welsh, Paul I. Welsh, Patrick Barry Mark, Carlos A. Celis-Morales, Jim Lewsey, Stuart Robert Gray, Donald M. Lyall, Stamatina Iliodromiti, Jason M. R. Gill, Jill P. Pell et al. · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
8. Association between dietary inflammatory index and Stroke in the US population: evidence from NHANES 1999–2018
   Yukang Mao, Jiayi Weng, Qiyang Xie, Li‐Da Wu, Yanling Xuan, Jun Zhang, Jun Han · 2024 · BMC Public Health
9. Inflammation in Renal Transplantation
   Sadollah Abedini, Ingar Holme, Winfried Ma[Combining Diaeresis]rz, Gisela Weihrauch, Bengt Fellstro[Combining Diaeresis]m, Alan G. Jardine, Edward Cole, Bart Maes, Hans‐Hellmut Neumayer, Carola Grönhagen‐Riska et al. · 2009 · Clinical Journal of the American Society of Nephrology
10. Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure–function relation to therapeutic inhibition
    Gianpaolo Tibolla, Giuseppe Danilo Norata, Roberto Artali, Fiorella Meneghetti, Alberico Luigi Catapano · 2011 · Nutrition Metabolism and Cardiovascular Diseases
11. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease
    Truls Sylvan Ingebrigtsen, Jacob Louis Marott, Børge Grønne Nordestgaard, Peter Lange, Jesper Hallas, Jørgen Vestbo · 2014 · Thorax
12. Rosuvastatin in Diabetic Hemodialysis Patients
    Hallvard Holdaas, Ingar Holme, Roland Erich Schmieder, Alan G. Jardine, Faiez M. Zannad, Gudrun E. Norby, Bengt Fellström · 2011 · Journal of the American Society of Nephrology
13. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk
    Patrick R. Lawler, Akintunde O. Akinkuolie, Paulette D. Chandler, M. Vinayaga Moorthy, Martin VanDenburgh, Debra Ann Schaumberg, I-min M Lee, Robert J. Glynn, Paul M. Ridker, Julie E. Buring et al. · 2016 · Circulation Research
14. Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis
    Harpreet Singh Bhatia, Simon Wandel, Peter Willeit, Anastasia Lesogor, Keith Bailey, Paul M. Ridker, Paul John Nestel, Robert John Simes, Andrew Maxwell Tonkin, Gregory G. Schwartz et al. · 2024 · Circulation
15. Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial
    Pradhan, Aruna D., Everett, Brendan M., Cook, Nancy R., Rifai, Nader, Ridker, Paul M · 2009 · JAMA
16. Lipids and lipid management in diabetes
    Mamta Jaiswal, Ashley Schinske, Rodica Pop‐Busui · 2013 · Best Practice & Research Clinical Endocrinology & Metabolism
17. Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low‐grade inflammation the neglected component?
    Francesco Prattichizzo, Valeria De Nigris, Stefano Micheloni, Lucia La Sala, Antonio Ceriello · 2018 · Diabetes Obesity and Metabolism
18. 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
    2022 · PubMed Central
19. Role of Vascular Inflammation in Coronary Artery Disease: Potential of Anti-inflammatory Drugs in the Prevention of Atherothrombosis
    Daniel Medeiros Moreira, Roberto Léo da Silva, Jefferson Luís Vieira, Tammuz Fattah, Maria Emília Lueneberg, Carlos Antônio Mascia Gottschall · 2014 · American Journal of Cardiovascular Drugs
20. Effect of monoclonal antibodies to PCSK9 on high‐sensitivity C‐reactive protein levels: a meta‐analysis of 16 randomized controlled treatment arms
    Sahebkar, Amirhossein, Di Giosia, Paolo, Stamerra, Cosimo Andrea, Grassi, Davide, Pedone, Claudio, Ferretti, Gianna, Bacchetti, Tiziana, Ferri, Claudio, Giorgini, Paolo · 2016 · British Journal of Clinical Pharmacology
21. Are statins diabetogenic?
    Uchechukwu K.A. Sampson, MacRae F. Linton, Sergio Fazio · 2011 · Current Opinion in Cardiology
22. One-step homogeneous C-reactive protein assay for saliva
    Chamindie Punyadeera, Goce Dimeski, Karam Kostner, Peter Beyerlein, Justin John Cooper-White · 2011 · Journal of Immunological Methods
23. Therapeutic Approaches to Target Inflammation in Type 2 Diabetes
    Allison B. Goldfine, Vivian Andrew Fonseca, Steven E. Shoelson · 2010 · Clinical Chemistry
24. Role of diuretics, blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study
    Long Shen, Bimal R. Shah, Eric Reyes, Laine Elliott Thomas, DANIEL M. WOJDYLA, Peter Diem, Larry A. Leiter, Bernard H. Charbonnel, Mareev VIu, Edward S. Horton et al. · 2013 · BMJ
25. Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology
    José Tuñón, Lina Badimón, Marie‐Luce Bochaton‐Piallat, Bertrand Cariou, Mat J.A.P. Daemen, Jesús Egido, Paul Charles Evans, Imo E. Hoefer, Daniel F.J. Ketelhuth, Esther Lutgens et al. · 2018 · Cardiovascular Research
26. Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
    Erik Ingelsson, Li Yin, Magnus Bäck · 2012 · Journal of Allergy and Clinical Immunology
27. CRP and suPAR are differently related to anthropometry and subclinical organ damage
    Stig Lyngbæk, Thomas Berend Sehestedt, Jacob Louis Marott, Tine W. Hansen, Michael Hecht Olsen, Ove Andersen, Allan R Linneberg, Sten Madsbad, Steen B. Haugaard, Jesper Eugen‐Olsen et al. · 2012 · International Journal of Cardiology
28. Primary Prevention of Atherosclerosis
    Claudio Napoli A, Valeria Crudele, Andrea Soricelli, Mohammed A. Al-Omran, Nicoletta Vitale, Teresa Infante, Francesco Paolo Mancini · 2012 · Circulation
29. A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)
    Vikas Pai, Arunachalam Paneerselvam, Satinath Mukhopadhyay, Anil Kumar Bhansali, Dinesh Kamath, V Shankar, Dhiraj Gambhire, Rajendrakumar H. Jani, Shashank Joshi, Pankaj Patel · 2014 · Journal of Diabetes Science and Technology
30. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial
    J. M. Pena, Jean G. MacFadyen, RJ Glynn, Paul M. Ridker · 2011 · European Heart Journal
31. Inflammation in Coronary Microvascular Dysfunction
    Sagris, Marios, Theofilis, Panagiotis, Antonopoulos, Alexios S., Oikonomou, Evangelos, Paschaliori, Christina, Galiatsatos, Nikolaos, Tsioufis, Kostas, Tousoulis, Dimitris · 2021 · International Journal of Molecular Sciences
32. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis
    Byrne, Paula, Demasi, Maryanne, Jones, Mark, Smith, Susan M., O’Brien, Kirsty K., DuBroff, Robert · 2022 · JAMA Internal Medicine
33. An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy
    Vijay U. Rao, Andrey Pavlov, Micki Klearman, David R. Musselman, Jon T. Giles, Joan M. Bathon, Naveed A. Sattar, Janet Lee · 2014 · Arthritis & Rheumatology
34. Pharmacological strategies for lowering LDL cholesterol: statins and beyond
    Ariel Brautbar, Christie Mitchell Ballantyne · 2011 · Nature Reviews Cardiology
35. Statins and the risk of colorectal cancer: An updated systematic review and meta-analysis of 40 studies
    Theodore Lytras · 2014 · World Journal of Gastroenterology
36. Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
    Jacoba P. Greving, Frank L.J. Visseren, G. Ardine de Wit, Ale Algra · 2011 · BMJ
37. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells
    Rosa Suades, Teresa Padró, Rodrigo Alonso K, Pedro Mata, Lina Badimón · 2013 · Thrombosis and Haemostasis
38. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women
    Jamal S. Rana, Benoît J. Arsenault, Jean‐Pierre Després, M. Cote, Philippa J. Talmud, Ewa Ninio, J. Wouter Jukema, Nicholas J. Wareham, John J.P. Kastelein, Kay‐Tee Khaw et al. · 2009 · European Heart Journal
39. The relevance of pathophysiological alterations in redox signaling of 4-hydroxynonenal for pharmacological therapies of major stress-associated diseases
    Morana Jaganjac, Lidija Milković, Agnieszka Gęgotek, Marina Cindrić, Kamelija Žarković, Elźbieta Skrzydlewska, Neven Žarković · 2019 · Free Radical Biology and Medicine
40. Statins and Inflammation
    Martin Satny, Jaroslav Alois Hubacek, Michal Vrablík · 2021 · Current Atherosclerosis Reports
41. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries
    Tanja Zeller, Maria Hughes, Tarja Palosaari, Arne Schillert, Annette Conrads‐Frank, Hester M. den Ruijter, Renate B. Schnabel, Frank Kee, Veikko V Salomaa, Uwe Siebert et al. · 2014 · European Journal of Epidemiology
42. Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies
    Seung Hwan Han, Ichiro Sakuma, Eak Kyun Shin, Kwang Kon Koh · 2009 · Progress in Cardiovascular Diseases
43. C-reactive protein and all-cause mortality--the Copenhagen City Heart Study
    Jeppe Zacho, A. Tybjærg–Hansen, Børge Grønne Nordestgaard · 2010 · European Heart Journal
44. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial
    Marc Atkin, David W Laight, Michael H. Cummings · 2016 · Journal of Diabetes and its Complications
45. Biomarkers: hopes and challenges in the path from discovery to clinical practice
    Nikolaos Georgios Frangogiannis · 2012 · Translational research
46. Gut Microbiome and Cardiovascular Diseases
    Naofumi Yoshida, Tomoya Yamashita, Ken‐ichi Hirata · 2018 · Diseases
47. Management of Familial Hypercholesterolemia: A Review of the Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
    Jennifer G. Robinson · 2013 · Journal of Managed Care Pharmacy
48. Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs
    Solomon, Daniel H., Curtis, Jeffrey R., Saag, Kenneth G., Lii, Joyce, Chen, Lang, Harrold, Leslie R., Herrinton, Lisa J., Graham, David J., Kowal, Mary K., Kuriya, Bindee et al. · 2013 · The American Journal of Medicine
49. Mechanisms of obesity and related pathologies: Androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction
    Abdulmaged M. Traish, Robert J. Feeley, André T. Guay · 2009 · FEBS Journal
50. Statins and the risk of new-onset diabetes
    David Preiss, Naveed A. Sattar · 2011 · Current Opinion in Lipidology
51. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
    RICHARD J. KONES · 2010 · Drug Design Development and Therapy
52. Obesity without Established Comorbidities of the Metabolic Syndrome Is Associated with a Proinflammatory and Prothrombotic State, Even before the Onset of Puberty in Children
    Nelly Mauras, Charles DelGiorno, Craig Kollman, Keisha Bird, Melissa A. Morgan, Shawn Sweeten, Prabhakaran Balagopal, Ligeia C Damaso · 2010 · The Journal of Clinical Endocrinology & Metabolism
53. S100A12 and the S100/Calgranulins
    Adam Oesterle, Marion A. Hofmann Bowman · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
54. A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications
    Evangelos K. Oikonomou, Marianna Leopoulou, Panagiotis Theofilis, Alexios S. Antonopoulos, Gerasimos Siasos, George Latsios, Vasiliki Chara Mystakidi, Charalambos A. Antoniades, Dimitris Tousoulis · 2020 · Atherosclerosis
55. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes
    Stefano Ciardullo, Gianluca Perseghin · 2021 · Metabolism
56. Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
    Rosalba La Grotta, Paola de Candia, Fabiola Olivieri, Giulia Matacchione, Angelica Giuliani, Maria Rita Rippo, Elena Tagliabue, Monica Mancino, Francesca Rispoli, Sabina Ferroni et al. · 2022 · Cellular and Molecular Life Sciences
57. Inflammatory markers in coronary heart disease
    Mohammad Madjid, James T. Willerson · 2011 · British Medical Bulletin
58. Statin myotoxicity: a review of genetic susceptibility factors
    Needham, M., Mastaglia, F.L. · 2014 · Neuromuscular Disorders
59. Charting a Roadmap for Heart Failure Biomarker Studies
    Tariq Ahmad, Mona Fiuzat, Michael J. Pencina, Nancy L. Geller, Faiez M. Zannad, John G.F. Cleland, James Snider, Stephan Blankenberg, Kirkwood F. Adams, Rita F. Redberg et al. · 2014 · JACC Heart Failure
60. Emerging views of statin pleiotropy and cholesterol lowering
    Dongbo Yu, James K. Liao · 2021 · Cardiovascular Research
61. Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment
    Huailan Wang, Yunxiang Zhou, Qunan Sun, Chenghao Zhou, Shiyao Hu, Cameron Lenahan, Weilin Xu, Yongchuan Deng, Gonghui Li, Sifeng Tao · 2021 · Frontiers in Bioengineering and Biotechnology
62. 2023 China Guidelines for Lipid Management
    Jian‐Jun Li, Shui‐Ping Zhao, Dong Zhao, Guoping Lü, Daoquan Peng, Jing Liu, Zhen‐Yue Chen, Yuan‐Lin Guo, Na‐Qiong Wu, Sheng-kai Yan et al. · 2023 · 老年心脏病学杂志：英文版
63. The role of statins in the prevention of preeclampsia
    Devin D. Smith, Maged M. Costantine · 2020 · American Journal of Obstetrics and Gynecology
64. Multi-omics approaches for revealing the complexity of cardiovascular disease
    Stephen F. Doran, Muhammad Arif, Simon C.C. Lam, Abdulahad Bayraktar, Hasan Türkez, Mathias Uhlén, Jan Borén, Adil Mardinoğlu · 2021 · Briefings in Bioinformatics
65. Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
    Chris J. Packard, M. John Chapman, Mahendra Sibartie, Ulrich Laufs, L. Masana · 2021 · Heart
66. Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review
    Tanvi Banait, Anil Wanjari, Vedika Danade, Shashank Banait, Jyoti Jain · 2022 · Cureus
67. C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation
    Duk‐Woo Park, Sung‐Cheol Yun, Jong‐Young Lee, Won‐Jang Kim, Soo‐Jin Kang, Seung‐Whan Lee, Young‐Hak Kim, Cheol Whan Lee, Jae‐Joong Kim, Seong‐Wook Park et al. · 2009 · Circulation
68. Statins and inflammation: an update
    Petter Quist‐Paulsen · 2010 · Current Opinion in Cardiology
69. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
    Alexander Tenenbaum, Enrique Z. Fisman · 2012 · Cardiovascular Diabetology
70. Diagnosis and Management of Statin Intolerance
    Rodrigo Alonso K, Ada M. Cuevas, Alberto Cafferata · 2019 · Journal of Atherosclerosis and Thrombosis
71. Clinical application of the new classification of periodontal diseases: Ground rules, clarifications and “gray zones”
    Kenneth S. Kornman, Panos N. Papapanou · 2019 · Journal of Periodontology
72. Arteriosclerosis e inflamación. Nuevos enfoques terapéuticos
    Juan Pedro‐Botet, Elisenda Climent, David Benaiges · 2020 · Medicina Clínica
73. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study
    Shujie Wang, Huahui Ren, Huanzi Zhong, Xinjie Zhao, Changkun Li, Jing Ma, Xuejiang Gu, Yaoming Xue, Shan Huang, Jialin Yang et al. · 2021 · Gut Microbes
74. Clinical Trial Design for Lipoprotein(a)-Lowering Therapies
    Waqas A. Malick, Sascha N. Goonewardena, Wolfgang Köenig, Robert S. Rosenson · 2023 · Journal of the American College of Cardiology
75. Benefit of Early Statin Therapy in Patients With Acute Myocardial Infarction Who Have Extremely Low Low-Density Lipoprotein Cholesterol
    Ki Hong Lee, Myung Ho Jeong, Ha Mi Kim, Youngkeun Ahn, Jong‐Hyun Kim, Shung Chull Chae, Young Jo Kim, Seung‐Ho Hur, In Whan Seong, Taek Jong Hong et al. · 2011 · Journal of the American College of Cardiology
76. Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study
    Jonathan M. Meyer, Joseph P. McEvoy, Vicki Grey Davis, DONALD C. GOFF, Henry A. Nasrallah, Sonia Thomas, John Hsiao, Marvin S. Swartz, T. Scott Stroup, Jeffrey Alan Lieberman · 2009 · Biological Psychiatry
77. On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy
    Samia Mora, Robert J. Glynn, S. Matthijs Boekholdt, Børge Grønne Nordestgaard, John J.P. Kastelein, Paul M. Ridker · 2012 · Journal of the American College of Cardiology
78. Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
    Rima F Kaddurah-Daouk, Rebecca Baillie, Hongjie Zhu, Zhao‐Bang Zeng, Michelle M. Wiest, Uyen Thao Nguyen, Steven M. Watkins, Ronald M. Krauss · 2010 · Metabolomics
79. Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levels
    Daniel Howard Steinberg, Joseph Lee Witztum · 2009 · Proceedings of the National Academy of Sciences
80. Abdominal Adiposity Is Associated With Elevated C-Reactive Protein Independent of BMI in Healthy Nonobese People
    Emanuela Lapice, Simona Maione, Lidia Patti, Paola Cipriano, Angela Albarosa Rivellese, Gabriele Riccardi, Olga Vaccaro · 2009 · Diabetes Care
81. Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial
    Eileen Mary Handberg, C. Noel Bairey Merz, Rhonda M. Cooper‐DeHoff, Janet Wei, Michael Conlon, Margaret C. Lo, William E. Boden, Susan M. Frayne, Todd C. Villines, John A. Spertus et al. · 2021 · American Heart Journal
82. Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study
    Robert J. Glynn, Jean G. MacFadyen, Paul M. Ridker · 2008 · Clinical Chemistry
83. Despite Antiatherogenic Metabolic Characteristics, SCD1-Deficient Mice Have Increased Inflammation and Atherosclerosis
    Marcia L.E. MacDonald, Miranda Van Eck, Reeni B. Hildebrand, Brian W. Wong, Nagat Bissada, Piers Ruddle, Anatol Kontush, Hala Hussein, Mahmoud A. Pouladi, M. John Chapman et al. · 2008 · Arteriosclerosis Thrombosis and Vascular Biology
84. C-Reactive Protein as a Prognostic Marker After Lacunar Stroke
    Mitchell S.V. Elkind, Jorge M. Luna, Leslie Ain McClure, Yu Zhang, Christopher S. Coffey, Ana Roldan, Óscar H. Del Brutto, Edwin Javier Pretell, Luther Creed Pettigrew, Brett Cowan Meyer et al. · 2014 · Stroke
85. Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction
    Kristian M. Bailey, Simon P.R. Romaine, Beryl M. Jackson, Amanda J Farrin, Maria Efthymiou, Julian H. Barth, Joanne Copeland, Terry McCormack, A. L. Whitehead, Marcus D Flather et al. · 2010 · Circulation Cardiovascular Genetics
86. Chinese Guideline on the Primary Prevention of Cardiovascular Diseases
    Chinese Society of Cardiology of Chinese Medical Association, Cardiovascular Disease Prevention and Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiovascular Disease Committee of Chinese Association of Gerontology and Geriatrics, Thrombosis Prevention and Treatment Committee of Chinese Medical Doctor Association · 2021 · Cardiology Discovery
87. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
    Bernard J. Gersh · 2011 · Yearbook of Cardiology
88. Association of C-Reactive Protein With Cardiovascular Disease Mortality According to Diabetes Status
    Kengne, Andre Pascal, Batty, G. David, Hamer, Mark, Stamatakis, Emmanuel, Czernichow, Sébastien · 2012 · Diabetes Care
89. IL-6 and its receptors in coronary artery disease and acute myocardial infarction
    Daniel R. Anderson, Joseph T. Poterucha, Ted R. Mikuls, Michael J. Duryee, Robert P. Garvin, Lynell W. Klassen, Scott W. Shurmur, Geoffrey M. Thiele · 2013 · Cytokine
90. Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk
    Haseeb Jafri, Alawi A.A. Alsheikh-Ali, Richard H. Karas · 2010 · Annals of Internal Medicine
91. Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy
    Masanori Abe, Noriaki Maruyama, Kazuyoshi Okada, Shiro Matsumoto, Koichí Matsumoto, Masayoshi Soma · 2011 · Journal of Atherosclerosis and Thrombosis
92. Association of malnutrition–inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients
    Manoch Rattanasompattikul, Miklos Zsolt Molnar, Joshua J. Zaritsky, Parta Hatamizadeh, Jennie Jing, Keith C. Norris, Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh · 2012 · Nephrology Dialysis Transplantation
93. Pharmacological Treatment and Current Management of Peripheral Artery Disease
    Marc P. Bonaca, Mark A. Creager · 2015 · Circulation Research
94. Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
    Marco Vugman Wainstein, Márcio Mossmann, Gustavo Neves de Araújo, Sandro Cadaval Gonçalves, Gabriela Leal Gravina, Marlei Sangalli, Francine Veadrigo, Roselene Matte, Rejane Reich, Fernanda Guimarães Costa et al. · 2017 · Diabetology & Metabolic Syndrome
95. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
    Florian Thibord, Derek M. Klarin, Jennifer A. Brody, Ming‐Huei Chen, Michael G. Levin, Daniel I. Chasman, Ellen L. Goode, Kristian Hveem, Maris Teder‐Laving, Ángel Martínez-Pérez et al. · 2022 · Circulation
96. Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers
    Natália R. Barbaro, Vanessa Fontana, Rodrigo Modolo, Ana Paula de Faria, Andrea Rodrigues Sabbatini, Francisco Antônio Helfenstein Fonseca, Gabriel Forato Anhê, Heitor Moreno · 2014 · Blood Pressure
97. Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers
    Stephen S. Hecht, Fekadu Kassie, Dorothy K. Hatsukami · 2009 · Nature reviews. Cancer
98. Statins are diabetogenic – Myth or reality?
    Naveed A. Sattar, Marja‐Riitta Taskinen · 2012 · Atherosclerosis Supplements
99. A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change
    Ligia Maria Belalcazar, David M. Reboussin, Steven M. Haffner, Ron Cornelis Hoogeveen, Andrea M. Kriska, Dawn C. Schwenke, Russell P. Tracy, Xavier Pi-Sunyer, Christie Mitchell Ballantyne · 2010 · Diabetes Care
100. Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs-CRP With Disease Severity in Coronary Artery Disease
     Alireza Yaghoubi, Morteza Ghojazadeh, Sakhavat Abolhasani, Hossein Alikhah, Fatemeh Khaki‐Khatibi · 2015 · Journal of Cardiovascular and Thoracic Research